Group One Trading
PLRX icon

Group One Trading’s Pliant Therapeutics PLRX Stock Holding History

Group One Trading’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.76K Sell
1,400
-900
-39% -$1.14K ﹤0.01% 7088
2025
Q4 		$2.81K Buy
2,300
+700
+44% +$1.05K ﹤0.01% 7426
2025
Q3 		$2.37K Buy
1,600
+1,400
+700% +$2.14K ﹤0.01% 7852
2025
Q2 		$232 Buy
+200
New +$283 ﹤0.01% 7732
2024
Q1 		– Sell
-300
Closed -$5.43K – 7764
2023
Q4 		$5.43K Sell
300
-4,000
-93% -$60.8K ﹤0.01% 6468
2023
Q3 		$74.6K Sell
4,300
-90,800
-95% -$1.57M ﹤0.01% 4727
2023
Q2 		$1.72M Buy
95,100
+90,800
+2,112% +$2.15M 0.01% 1850
2023
Q1 		$114K Sell
4,300
-4,800
-53% -$137K ﹤0.01% 4195
2022
Q4 		$176K Hold
9,100
– – ﹤0.01% 3960
2022
Q3 		$190K Buy
+9,100
New +$174K ﹤0.01% 4195

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Group One Trading's PLRX Position: Q1 2026 in Review

Group One Trading sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 15,790 shares — an estimated $19.9K sold.

Group One Trading first reported a position in PLRX in Q1 2023 and held it in 11 quarters. The position peaked at $276K in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Group One Trading reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 15,790 Pliant Therapeutics shares in Q1 2026, an estimated $19.9K.
  • Group One Trading first reported a position in Pliant Therapeutics in Q1 2023 and held it in 11 quarters.
  • Group One Trading's Pliant Therapeutics position peaked at $276K in Q1 2023.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.